Ushanti Colour Chem Limited Allots Equity Shares Following Warrants Conversion
Ushanti Colour Chem Limited announced the allotment of 16,57,000 equity shares following the exercise of convertible warrants. The decision was made at a board meeting held on Tuesday, March 31, 2026.The allotment is linked to 16,57,000 warrants previously issued to non-promoter allottees on a preferential basis. Warrant holders paid the remaining 75% of the issue price, triggering the board's approval for the equity share allotment. The equity shares were issued at an issue price of ₹ 58 per share.
The company had previously allotted 26,50,000 convertible equity warrants on February 12, 2026, with an issue price of ₹ 58 per warrant, with 25% paid upfront.
Details of Allottees and Share Allocation:
| Sr. No | Name of the Allottee(s) | Number of Equity Shares Allotted against Conversion of Warrants | Issue Price per Equity Share (In INR) |
|---|---|---|---|
| 1 | Manish I Mehta | 50,000 | 58 |
| 2. | Moksha Mehta | 50,000 | 58 |
| 3. | Shweta Samirbhai Shah | 3,00,000 | 58 |
| 4. | Samir R Shah HUF | 2,30,000 | 58 |
| 5. | Parshwa Shah | 25,000 | 58 |
| 6. | Parthivsinh Solanki | 50,000 | 58 |
| 7. | Swetsam Stock Holding Private Limited | 6,45,000 | 58 |
| 8. | Kinnariben Mehulbhai Shah | 25,000 | 58 |
| 9. | Naresh Surajmal Shah | 96,000 | 58 |
| 10. | Nareshbhai Surajmal Shah HUF | 96,000 | 58 |
| 11. | S NShah HUF | 90,000 | 58 |
| Total | Total | 16,57,000 | 58 |
Following the allotment, the company's paid-up equity share capital increased from ₹ 12,22,97,000 to ₹ 13,88,67,000. The newly issued shares will rank pari passu with existing shares. The company will seek listing and trading approval from the National Stock Exchange in due course.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.